[BIB] ProShares Ultra Nasdaq Biotechnology ETF

Overview

Type of security: Fund

Tags: 2X, Biotech, Country, Equity, ETF, Health care, Index Based, Leveraged, Not Inversed, Stocks, U.S.

The data is delayed by 15 minutes.

 

Price: 42.04 Change: 1.74 (4.32%)
Ext. hours: Change: 0 (0%)

chart BIB

Refresh chart

Strongest Trends Summary For BIB

BIB is in the long-term down -58% below S&P in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

Technical Data
High 52 week70.14 Low 52 week36.42 Last close53.14 Last change-1.13%
RSI85.22 Average true range2.43 Beta2.16 Volume382.3 K
Simple moving average 20 days15.79% Simple moving average 50 days8.36% Simple moving average 200 days-6.75%
Performance Data
Performance Week1.8% Performance Month11.38% Performance Quart-6.06% Performance Half-19.81%
Performance Year-11.46% Performance Year-to-date26.25% Volatility daily4.67% Volatility weekly10.44%
Volatility monthly21.39% Volatility yearly74.08% Relative Volume147.41% Average Volume225.48 K
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio1.32% Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio0.95% Total net assets347.61 M
Weighted market capitalization

Info

Characteristics:
NAME VALUE
Gross Expense Ratio1,32
Total Expense Ratio0,95
Total Net Assets347.61 million
Top Holdings:
NAME VALUE
Amgen Inc.8,92
Biogen Idec Inc.8,05
Celgene Corp.7,79
Gilead Sciences Inc.7,68
Alexion Pharmaceuticals Inc.6,79
Regeneron Pharmaceuticals Inc.4,05
Vertex Pharmaceuticals Inc.3,92
Illumina Inc.3,89
Biomarin Pharmaceutical Inc.2,37
Incyte Corp.2,14
Sector Breakdown:
NAME VALUE
Biotechnology74,47
Pharmaceuticals22,61
Health Care Products2,54
Diversified0,24
Commercial Services0,14

News

2019-06-25 10:50:10 | BIB Versus LABU: Comparing Leveraged Biotech ETFs

2019-05-07 16:57:08 | Biotech ETFs in Focus on String of Q1 Earnings Beats

2019-04-24 16:04:08 | Will Biotech ETFs Continue to Rally in Q1 Earnings?

2019-03-05 15:32:00 | Biotech stocks turn lower after reports of FDA commissioner resigning

2018-12-11 15:32:14 | Trump Foreshadows a Bleak Outlook for Biotech IBB, BIB

2018-10-29 09:15:01 | Stocks Still Looking for the Bottom

2018-10-19 15:47:23 | Swing Trade In Biotech Sector Gave The Best Of Both Worlds

2018-09-12 09:57:38 | Major Biotech ETFs Had Lackluster Performance in the Past Month

2018-06-15 14:55:46 | Biotech Funds Tacked On $76 Million This Week — Are They Recovering?

2018-01-10 11:07:04 | Bayer and J&J win big, Microsoft lags because of Intel, Apple turns over information

2017-12-04 16:42:15 | How Biotechs, Drugmakers Would Fare Under The Senate's Tax Bill

2017-09-15 15:26:33 | Biotech, Pharma ETFs Leave Pricing Drama Behind

2017-09-08 10:31:42 | Biotech ETF Investing is Hot, Can Get Hotter

2017-08-31 13:39:08 | Why $475,000 isn't actually that expensive for Novartis's new drug

2017-08-30 10:53:17 | Biotech ETF Investing is Starting to Look Good – Here’s Why

2017-08-25 07:37:10 | Must-Know Developments for Ionis Pharmaceuticals

2017-03-15 08:26:43 | Biotech is Bubbling Up

2017-01-30 10:24:00 | Biotech Suffered Big Outflows Again Last Week, Pushing Back A Recovery

2017-01-18 06:00:00 | Trump Foreshadows a Bleak Outlook for Biotech

2017-01-06 11:37:00 | The Most-Shorted Stocks In Health Care In 2016 Were…

2017-01-04 12:25:00 | Will Biotech Find Its Footing In 2017?

2016-12-21 10:35:45 | What Are Analysts Saying about Horizon Pharma?

2016-12-19 11:29:30 | Horizon Pharma’s Steep Fall in December: What Happened?

2016-12-09 16:14:00 | Biotech ETFs: A Short-Lived Boon From Biogen

2016-11-18 16:53:06 | Could This Stock Offer Another Profit Opportunity?

2016-11-11 17:58:33 | Letting Postelection Dust Settle For Next Opportunities

2016-10-28 11:37:12 | BUZZ-Biotech ETF weakness grows more acute

2016-10-17 12:40:31 | What Will Rising Crude Oil Inventories Mean for Crude Oil Movement?

2016-10-17 10:32:22 | Implied Volatilities: Crude Oil and Natural Gas

2016-10-14 15:06:49 | Analyzing US Crude Oil Inventories by Region: The Latest

2016-10-12 09:24:31 | Will API Inventory Report Limit Upside for Crude Oil Prices?

2016-10-11 13:03:59 | How Inventories and OPEC Decision Are Affecting Crude Prices

2016-10-10 12:30:51 | Crude Oil and Natural Gas: Analyzing Implied Volatilities

2016-10-03 17:04:36 | What Were the Implied Volatilities for Crude Oil and Natural Gas?

2016-10-03 17:04:35 | What’s the Natural Gas Outlook for This Week?

2016-09-26 11:12:22 | Options Traders: The Implied Volatility of Crude Oil and Natural Gas

2016-09-26 11:12:21 | Why the Weather Could Mean Trouble for Natural Gas Bulls

2016-09-20 14:04:06 | Buy Allows Horizon to Further Expand into Orphan Drug Space

2016-09-20 12:04:07 | How OPEC’s Decision Will Impact Crude Oil’s Movement

2016-09-19 09:30:33 | Analyzing the Implied Volatilities of Crude Oil and Natural Gas

2016-09-19 09:30:32 | Natural Gas Traders Should Watch This Weather Report

2016-09-12 11:05:01 | Crude Oil Prices Jumped as Inventories Fell

2016-09-12 09:31:08 | A Look into the Implied Volatilities of Crude Oil and Natural Gas

2016-09-12 09:31:07 | How Weather Could Be a Bullish Catalyst for Natural Gas

2016-09-06 10:26:26 | How Could the Weather Impact Natural Gas Prices?

2016-09-01 08:06:16 | What Does The Price Action in Natural Gas Indicate?

2016-08-29 15:32:03 | Implied Volatilities of Crude Oil, Natural Gas in Focus

2016-08-25 10:08:42 | What’s Driving Natural Gas Prices Higher?